glp 1 agonist 종류 Glucagon-Like Peptide 수용체작용제 최신지견 GLP-1 Agonists - What is
Description
Goodwin S
Sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease
Jensen EP, Poulsen SS, Kissow H, Holstein-Rathlou NH, Deacon CF, Jensen BL, et al
The role of emerging therapies The diabetes and obesity treatment landscape continues to evolve rapidly
[DOI] [PubMed] [Google Scholar] 86.Henderson BE, Lee NH, Seewaldt V, Shen H
It works by boosting insulin release in response to high blood sugar levels following a meal and lowering sugar production by the liver
